These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7822882)

  • 1. Centrally acting skeletal muscle relaxants and associated drugs.
    Waldman HJ
    J Pain Symptom Manage; 1994 Oct; 9(7):434-41. PubMed ID: 7822882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle relaxants.
    See S; Ginzburg R
    Pharmacotherapy; 2008 Feb; 28(2):207-13. PubMed ID: 18225966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [When and how to prescribe muscle relaxants in spasticity ?].
    Delwaide PJ; Burton L
    Rev Med Liege; 1981 Apr; 36(7):268-71. PubMed ID: 7291810
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of oral skeletal muscle relaxants for the craniomandibular disorder (CMD) practitioner.
    Stanko JR
    Cranio; 1990 Jul; 8(3):234-43. PubMed ID: 2083431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle relaxants for pain management in rheumatoid arthritis.
    Richards BL; Whittle SL; Buchbinder R
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008922. PubMed ID: 22258993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally acting skeletal-muscle relaxants.
    Domino EF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):369-73. PubMed ID: 4850933
    [No Abstract]   [Full Text] [Related]  

  • 7. The management of cerebral palsy: subjectivity and a conundrum.
    Bodensteiner JB
    J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacology of spasticity].
    Morel N
    J Belge Med Phys Rehabil; 1980; 3(2):105-12. PubMed ID: 9139023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Lipták J
    Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
    [No Abstract]   [Full Text] [Related]  

  • 11. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
    Lapeyre E; Kuks JB; Meijler WJ
    NeuroRehabilitation; 2010; 27(2):193-200. PubMed ID: 20871149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current data on bipolar disorders, epilepsy and spasticity. 4. Neuro-Forum, Dresden].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Aktuelles):1-12. PubMed ID: 10368778
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle relaxants--the current position in the treatment of spasticity in orthopedics.
    Zygmunt M; Sapa J
    Ortop Traumatol Rehabil; 2015; 17(4):423-30. PubMed ID: 26468180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle relaxant drugs.
    Campbell ED
    Practitioner; 1979 Oct; 223(1336):507-9. PubMed ID: 523403
    [No Abstract]   [Full Text] [Related]  

  • 16. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orally administered drugs in the treatment of spasticity].
    Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):70-4. PubMed ID: 12861514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
    Chou R; Peterson K; Helfand M
    J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.